¥ê¥ó¥¯½¸
¥á¥¤¥ó | ÅÐÏ¿¤¹¤ë | ¿Íµ¤¥µ¥¤¥È (top10) | ¹âɾ²Á¥µ¥¤¥È (top10) | ¤ª¤¹¤¹¤á¥µ¥¤¥È (7) | Áê¸ß¥ê¥ó¥¯¥µ¥¤¥È (1) |
¥«¥Æ¥´¥ê°ìÍ÷ | RSS/ATOM Âбþ¥µ¥¤¥È (18) | RSS/ATOM µ»ö (63027) | ¥é¥ó¥À¥à¥¸¥ã¥ó¥× |
¥á¥¤¥ó
- ¿·Ãå ¥µ¥¤¥È- ¿·Ãå RSS/ATOM
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
¸½ºß¥Ç¡¼¥¿¥Ù¡¼¥¹¤Ë¤Ï62·ï¤Î¥ê¥ó¥¯¤¬ÅÐÏ¿¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¿·Ãå ¥µ¥¤¥È
¥·¥ê¡¼¥º °ÜưÃΡ¡Âè4´¬¡¡¼Ò²ñŬ±þ¡Ýȯ¸½µ¡¹½¤Èµ¡Ç½¾ã³²¨¡
![]() | |
¸¦µæ¶ÈÀÓ
Bibliography: ÂÀÅÄ¡¡½ç¡¤Àľ¿λ֡¡ÊÔÃø¡¤¥·¥ê¡¼¥º °ÜưÃΡ¡Âè4´¬¡¡¼Ò²ñŬ±þ¡¡¡Ýȯ¸½µ¡¹½¤Èµ¡Ç½¾ã³²¨¡ ... ºÇ½ª¹¹¿·Æü: 2010-2-28 ¥Ò¥Ã¥È¿ô: 1419 ¤â¤Ã¤È¾Ü¤·¤¯ |
Electroactive Polymer Gel Robots (Amazon)
![]() | |
¸¦µæ¶ÈÀÓ
Electroactive Polymer Gel Robots: Modelling and Control of Artificial Muscles (Springer Tracts i ... ºÇ½ª¹¹¿·Æü: 2010-2-28 ¥Ò¥Ã¥È¿ô: 2045 ¤â¤Ã¤È¾Ü¤·¤¯ |
Electroactive Polymer Gel Robots (Springer)
![]() | |
¸¦µæ¶ÈÀÓ
Bibliography: Mihoko Otake, Electroactive Polymer Gel Robots Modelling and Control of Artifi ... ºÇ½ª¹¹¿·Æü: 2010-2-28 ¥Ò¥Ã¥È¿ô: 3023 ¤â¤Ã¤È¾Ü¤·¤¯ |
¤Û¤Î¤Ü¤Î¸¦µæ½ê
![]() | |
¥Í¥Ã¥È¥ï¡¼¥¯
¤Û¤Î¤Ü¤Î¸¦µæ½ê¤Ï¡¢¹âÎð¼Ò²ñ¤Î½ôÌäÂê¡¢ÆÃ¤ËǧÃξɤ˴ؤ¹¤ë½ôÌäÂê¤ò²ò·è¤¹¤ë²Ê³Øµ»½Ñ¼Ò²ñ¥·¥¹¥Æ¥à¤Ë¤Ä¤¤ ... ºÇ½ª¹¹¿·Æü: 2009-9-6 ¥Ò¥Ã¥È¿ô: 2920 ¤â¤Ã¤È¾Ü¤·¤¯ |
¸¦µæ¤Î»Ô̱»²²Ã¤Ç²Ê³Øµ»½Ñ¤È¼Ò²ñ¤¬ÌÌÇò¤¯¤Ê¤ë
![]() | |
¸¦µæ¶ÈÀÓ
ÂçÉðÈþÊݻҡ¥¸¦µæ¤Î»Ô̱»²²Ã¤Ç²Ê³Øµ»½Ñ¤È¼Ò²ñ¤¬ÌÌÇò¤¯¤Ê¤ë¡¤2008ǯ¿·½ÕŸ˾¡¤Biotechnology Japan¡¤200 ... ºÇ½ª¹¹¿·Æü: 2009-9-6 ¥Ò¥Ã¥È¿ô: 2362 ¤â¤Ã¤È¾Ü¤·¤¯ |
ÆüËÜ̱麶¨²ñ
![]() ![]() ![]() | |
¸¦µæ¥Æ¡¼¥Þ
ÆüËÜ̱麶¨²ñ¤Ï¡¢ÆüËÜ̱麴ۤ¬¾¼ÏÂ11ǯ¤Ë³«´Û¤¹¤ë2ǯÁ°¡¢¾¼ÏÂ9ǯ¤ËÌø½¡±Ù¤ò½éÂå²ñĹ(¸½²ñĹ ¿åÈø ÈæÏ¤ ... ºÇ½ª¹¹¿·Æü: 2008-6-22 ¥Ò¥Ã¥È¿ô: 2742 ¤â¤Ã¤È¾Ü¤·¤¯ |
ÞÉ´Ö¸¦µæ¼¼
![]() | |
¥á¥ó¥Ð¡¼
ÞÉ´Ö¸¦µæ¼¼¤Ç¤Ï¡¢¿Í¤¬Ëþ¤¹¤ë¥µ¡¼¥Ó¥¹¤òÁϤ¤¹¤ëÊýË¡ÏÀ¤òÌÀ¤é¤«¤Ë¤·¡¢¾õ¶·¤Ë±þ¤¸¤ÆÅ¬Àڤʥµ¡¼¥Ó¥¹¤ò¥ª ... ºÇ½ª¹¹¿·Æü: 2007-1-27 ¥Ò¥Ã¥È¿ô: 3945 ¤â¤Ã¤È¾Ü¤·¤¯ |
»°Å縦µæ¼¼
![]() | |
¥á¥ó¥Ð¡¼
»°Å縦µæ¼¼¤Ç¤Ï¡¢³Ø³°µ¡´Ø¤È¤·¤ÆÍý²½³Ø¸¦µæ½ê¡Ê¾ðÊó´ðÈ׸¦µæ¥»¥ó¥¿¡¼¡¢À¸ÂÎÎϳإ·¥ß¥å¥ì¡¼¥·¥ç¥ó¸¦µæ¥× ... ºÇ½ª¹¹¿·Æü: 2007-1-27 ¥Ò¥Ã¥È¿ô: 1894 ¤â¤Ã¤È¾Ü¤·¤¯ |
BTJ¥¸¥ã¡¼¥Ê¥ëNo.013
![]() | |
¸¦µæ¶ÈÀÓ
BTJ¥¸¥ã¡¼¥Ê¥ëNo.013¡¡¡ÊÁÏ´©1¼þǯµÇ°¹æ¡Ë ³Ø²ñ¥³¥ì¥¯¥·¥ç¥ó¡Ö¤µ¤¤¬¤±¥é¥¤¥Ö2006¡×¤Ë¼Ì¿¿¤¬·ÇºÜ¤µ ... ºÇ½ª¹¹¿·Æü: 2007-1-27 ¥Ò¥Ã¥È¿ô: 2361 ¤â¤Ã¤È¾Ü¤·¤¯ |
BTJ¥¸¥ã¡¼¥Ê¥ë
![]() ![]() | |
¸¦µæ¶ÈÀÓ
¡ÖBTJ¥¸¥ã¡¼¥Ê¥ë¡×¤Ï¡¢Á´¹ñ5Ëü¿Í°Ê¾å¤Î¥Ð¥¤¥ª¸¦µæ¼Ô¤Î¥³¥ß¥å¥Ë¥Æ¥£¡Ö¥Ð¥¤¥ª¥Æ¥¯¥Î¥í¥¸¡¼¡¦¥¸¥ã¥Ñ¥ó¡×¤¬ ... ºÇ½ª¹¹¿·Æü: 2007-1-27 ¥Ò¥Ã¥È¿ô: 2061 ¤â¤Ã¤È¾Ü¤·¤¯ |
FujiSankei Business i.
![]() ![]() | |
¸¦µæ¶ÈÀÓ
¥Õ¥¸¥µ¥ó¥±¥¤¡¡¥Ó¥¸¥Í¥¹¥¢¥¤¡ÊÆüËܹ©¶È¿·Ê¹¼Ò¡Ë ºÇ½ª¹¹¿·Æü: 2007-1-11 ¥Ò¥Ã¥È¿ô: 3166 ¤â¤Ã¤È¾Ü¤·¤¯ |
Ǿ¤Î»É·ã¤òµ¿»÷ºÆ¸½¡¡ÅìÂç¡¢¥ê¥Ï¥Ó¥ê¤Ê¤É¼ÂÍѤØ
![]() ![]() | |
¸¦µæ¶ÈÀÓ
Bibliography: Ǿ¤Î»É·ã¤òµ¿»÷ºÆ¸½¡¡ÅìÂç¡¢¥ê¥Ï¥Ó¥ê¤Ê¤É¼ÂÍѤء¤FujiSankei Business i. ¡¤¥Õ¥¸¥µ¥ó¥± ... ºÇ½ª¹¹¿·Æü: 2007-1-11 ¥Ò¥Ã¥È¿ô: 1693 ¤â¤Ã¤È¾Ü¤·¤¯ |
ÃÎǽ¼Ò²ñ¥·¥¹¥Æ¥à¥³¡¼¥¹
![]() ![]() | |
¥×¥í¥¸¥§¥¯¥È
¿¤¯¤Î¹©³Ø¶µ°é¤ÏÀìÌçµ»½Ñ¤ËÆÃ²½¤·¤¿¶µ°é¤Î¤ß¤Ç¡¤¹Åľ¤·¤¿»º¶ÈÊ̤νijä¤ê¶µ°é¤ò¤·¤Æ¤¤¤Þ¤¹¡£¤·¤«¤·¡¤¹â ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 4588 ¤â¤Ã¤È¾Ü¤·¤¯ |
´Ä¶³¤Íι©³ØÀì¹¶
![]() | |
¥×¥í¥¸¥§¥¯¥È
ÅìµþÂç³ØÂç³Ø±¡¹©³Ø·Ï¸¦µæ²Ê´Ä¶³¤Íι©³ØÀì¹¶¤Ï¡¢¸½ºß¡¢¿ÍÎà¤Î»ý³Ū¤ÊȯŸ¤È¼«Á³¥·¥¹¥Æ¥à¤È¶¦À¸¤¹¤ëºÇ ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 1696 ¤â¤Ã¤È¾Ü¤·¤¯ |
¥µ¡¼¥Ó¥¹¹©³Ø¸¦µæÉôÌç
![]() | |
¥×¥í¥¸¥§¥¯¥È
ÅìµþÂç³Ø¿Í¹©Êª¹©³Ø¸¦µæ¥»¥ó¥¿¡¼¡¡¥µ¡¼¥Ó¥¹¹©³Ø¸¦µæÉôÌç ½Û´Ä·¿¼Ò²ñ¤Î¹½ÃۤΤ¿¤á¤Ë¤Ï¡¢ÂçÎÌÀ¸»º¡¦Âç ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 1850 ¤â¤Ã¤È¾Ü¤·¤¯ |
ÂÎ¤ÎÆ°¤¤«¤é¸«¤ëǾ
![]() | |
¸¦µæ¶ÈÀÓ
ÂÎ¤ÎÆ°¤¤«¤é¸«¤ëǾ ¿À·Ð·Ï¤ÎÁÐÊý¸þ¥Þ¥ë¥Á¥¹¥±¡¼¥ë¥·¥ß¥å¥ì¡¼¥¿¤Î³«È¯ ÂçÉð¡¡ÈþÊÝ»Ò ÅìµþÂç³Ø¡¡¿Í¹© ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 1616 ¤â¤Ã¤È¾Ü¤·¤¯ |
¤µ¤¤¬¤±¥é¥¤¥Ö2006
![]() | |
¸¦µæ¶ÈÀÓ
Æü»þ¡§2006ǯ12·î15Æü¡Ê¶â¡Ë¡Á16Æü¡ÊÅÚ¡Ë ²ñ¾ì¡§Åìµþ¹ñºÝ¥Õ¥©¡¼¥é¥à¡¡¥Û¡¼¥ëB7 ¢©100-0005 ÅìµþÅÔÀé ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 1529 ¤â¤Ã¤È¾Ü¤·¤¯ |
¿Í¹©Êª¹©³Ø¸¦µæ¥»¥ó¥¿¡¼
![]() | |
¥×¥í¥¸¥§¥¯¥È
ÅìµþÂç³Ø¿Í¹©Êª¹©³Ø¸¦µæ¥»¥ó¥¿¡¼¤Ï£±£¹£¹£²Ç¯¤ËÀßΩ¤µ¤ì¡¢£²£°£°£²Ç¯Å٤ˤÏÂèÆó´ü¤È¤·¤Æ¡¢¥é¥¤¥Õ¥µ¥¤¥¯ ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 2073 ¤â¤Ã¤È¾Ü¤·¤¯ |
RACE NEWS
![]() | |
¸¦µæ¶ÈÀÓ
ÅìµþÂç³Ø¿Í¹©Êª¹©³Ø¸¦µæ¥»¥ó¥¿¡¼¡¡¥Ë¥å¡¼¥º¥ì¥¿¡¼ ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 1652 ¤â¤Ã¤È¾Ü¤·¤¯ |
JST¡¢Ì¤Íè¤Î²ÄǽÀ¤ò³À´Ö¸«¤ë¡Ö¤µ¤¤¬¤±¥é¥¤¥Ö2006¡×³«ºÅ
![]() | |
¸¦µæ¶ÈÀÓ
Bibliography: ¿¹»³ÏÂÆ»¡¤JST¡¢Ì¤Íè¤Î²ÄǽÀ¤ò³À´Ö¸«¤ë¡Ö¤µ¤¤¬¤±¥é¥¤¥Ö2006¡×³«ºÅ¡¤Robot Watch¡¤¥¤¥ó ... ºÇ½ª¹¹¿·Æü: 2007-1-2 ¥Ò¥Ã¥È¿ô: 2088 ¤â¤Ã¤È¾Ü¤·¤¯ |
¿·Ãå RSS/ATOM
RSS/ATOM Âбþ¥µ¥¤¥È (18)RSS/ATOM µ»ö (63027)


¥¡¼¥ï¡¼¥É¤òÀìÌç»ïµ¼Ô¤¬¤ï¤«¤ê¤ä¤¹¤¯²òÀâ¡¢WBC¤Ç¤âÏÃÂê¤Ë¤Ê¤Ã¤¿¥á¥é¥È¥Ë¥ó¤È¤Ï from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-31 7:00) |
¡¡¥á¥é¥È¥Ë¥ó¡ÊMelatonin¡Ë¤Ï¿ç̲¤ä³ÐÀäΥꥺ¥à¤òÄ´À᤹¤ë¥Û¥ë¥â¥ó¡£ÂÀÍÛ¸÷¤Ê¤É´Ä¶¤«¤éÆþ¤ë¸÷»É·ã¤¬¼å¤Þ¤ë¤È¡¢Ç¾Æâ¤Î¾¾²ÌÂΤÇʬÈ礵¤ì¤ë¥á¥é¥È¥Ë¥ó¤ÎÎ̤¬Áý¤¨¤ë¡£µÕ¤Ë´Ä¶¸÷¤¬Â¿¤¤ÆüÃæ¤Ï¥á¥é¥È¥Ë¥ó¤ÎʬÈçÎÌ¤Ï ... |
ÊÆUltragenyx¼Ò¤ÎCEO¡¢Âè°ì»°¶¦¤¬Æ³Æþ¤·¤¿AAV¤ÎÀ½Â¤µ»½Ñ¤ÎÍøÅÀ¤Ê¤É¤òÀâÌÀ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-31 7:00) |
¡¡ÊÆUltragenyx Pharmaceutical¼Ò¤ÎÆüËÜË¡¿Í¤Ç¤¢¤ëUltragenyx Japan¤Ï¡¢2023ǯ3·î30Æü¡¢Æ±¼Ò¤ÎÁ϶ȼԤǤ¢¤ëEmil D. Kakkis CEO¤ÎÍèÆü¤Ë¤¢¤ï¤»¤Æµ¼Ô²ñ¸«¤ò³«ºÅ¡£Kakkis CEO¤Ï¡¢°äÅÁ»Ò¼£ÎŸþ¤±¤Î¥¢¥Ç¥Î¿ïȼ¥¦¥¤¥ë ... |
¥¦¥§¥ë¥Í¥¹¥Õ¡¼¥É¤ÎºÇ¿·¥°¥í¡¼¥Ð¥ë¥È¥ì¥ó¥É¡¢±ÉÍÜ¡¦·ò¹¯¿©ÉʻԾì¤Ë¤ª¤±¤ë5¤Ä¤Î¥á¥¬¥È¥ì¥ó¥É¤È10¤Î¥¡¼¥È¥ì¥ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-31 7:00) |
¡¡¥¦¥§¥ë¥Í¥¹¥Õ¡¼¥É¡Ê±ÉÍÜ¡¦·ò¹¯¿©Éʡ˻º¶È¤Î»ö¶È´Ä¶¤ÏÆü¡¹¡¢¹ï¡¹¤ÈÊѤï¤ê³¤±¤Æ¤¤¤ë¡£¿·À½Éʤγ«È¯¤ä¥Þ¡¼¥±¥Æ¥£¥ó¥°Àïά¤ÎΩ°Æ¤Ë¤Ï¡¢»Ô¾ìÊѲ½¤ä¥È¥ì¥ó¥É¤òÀè¼è¤ê¤·¤ÆÊ¬ÀϤ¹¤ë¤³¤È¤¬½ÅÍפǤ¢¤ë¡£É®¼Ô¤¬Âåɽ¤ò̳ ... |
¥Ð¥¤¥ª¥Ó¥¸¥Í¥¹¤ò¤È¤ê¤Þ¤¯¥È¥ì¥ó¥É²òÀâ¡Ê5¡Ë¡¢Äó·È¡¦Çã¼ý¤Ç¶¥Á褬·ã²½¤¹¤ë¥á¥¬¥Õ¥¡¡¼¥Þ¤Î¥Ñ¥¤¥×¥é¥¤¥óÀïά from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-31 7:00) |
¡¡¾å»Ô¡Ê»Ô¾ìÅêÆþ¡Ë¤Þ¤Ç¤Î´ü´Ö¤¬Èó¾ï¤ËŤ¤¿·Ìô³«È¯¤Ë¤ª¤¤¤Æ¡¢À¤³¦¤ÎÂç¼êÀ½Ìô´ë¶È¤Ï»ñËÜÎϤòÀ¸¤«¤·¤ÆÆ³Æþ¤·¤¿µ»½Ñ¤ä¸õÊäÉʤò´ð¤ËÎ×¾²³«È¯¤·¡¢¥¥ã¥Ã¥·¥å¤ò²ó¼ý¤¹¤ë¥Ó¥¸¥Í¥¹¥â¥Ç¥ë¤ò´ðËܤȤ·¤Æ¤¤¤ë¡£¿·Ìô³«È¯¤Î ... |
ž¼Ì°ø»ÒɸŪÌô¤ÎÊÆFlare¼Ò¡¢Ç¢Ï©¾åÈ餬¤ó¤ÎÎ×¾²Æþ¤ê¤Ë¸þ¤±161²¯±ßĴã from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-31 7:00) |
¡¡ÊÆFlare Therapeutics¼Ò¤Ï2023ǯ3·î22Æü¡¢¥·¥ê¡¼¥ºB¥é¥¦¥ó¥É¤ÇÌÜɸ³Û¤òͤ¨¤ë1²¯2300Ëü¥É¥ë¡ÊÌó161²¯±ß¡Ë¤òĴ㤷¤¿¤Èȯɽ¤·¤¿¡£Ç¢Ï©¾åÈ餬¤ó¤Î¼çÍמ¼Ì°ø»Ò¤Ç¤¢¤ë¥Ú¥ë¥ª¥¥·¥½¡¼¥àÁý¿£°ø»Ò³èÀ²½¼õÍÆÂÎ¥¬¥ó¥Þ ... |
ÂçºåÂç¤ÈÅçÄÅÀ½ºî½ê¤Ê¤É´ë¶È4¼Ò¡¢ÇÝÍÜÆù³«È¯¤Ç¥³¥ó¥½¡¼¥·¥¢¥àÀßΩ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-30 7:00) |
¡¡ÂçºåÂç³ØÂç³Ø±¡¹©³Ø¸¦µæ²Ê¡¢ÅçÄÅÀ½ºî½ê¡¢°ËÆ£¥Ï¥àÊÆµ×¥Û¡¼¥ë¥Ç¥£¥ó¥°¥¹¡Ê°Ê²¼°ËÆ£¥Ï¥àÊÆµ×¡Ë¡¢ÆÌÈǰõºþ¡¢¥·¥°¥Þ¥¯¥·¥¹¤Ï2023ǯ3·î29Æü¡¢ÇÝÍÜÆù¤Î»ö¶È²½¤Ë¸þ¤±¤¿¥³¥ó¥½¡¼¥·¥¢¥à¤òÀßΩ¤·¤¿¡£2025ǯ¤ÎÆüËܹñºÝÇî ... |
ºÆÀ¸°åÎųزñ2023¡ÊÀ½Â¤¼«Æ°²½¡Ë¡§»ºÁí¸¦¡¦²ÆÌÜ»á¡¢ÈÆÍÑÀ¥í¥Ü¥Ã¥È¤Î²ÁÃͤò¶¯Ä´ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-30 7:00) |
¡¡Âè22²óÆüËܺÆÀ¸°åÎųزñÁí²ñ¡Ê²ñ´ü¡§2023ǯ3·î23Æü¡Á25Æü¡Ë¤Ç¡¢¥·¥ó¥Ý¥¸¥¦¥à¡ÖºÆÀ¸°åÎŤ˻ñ¤¹¤ë¥í¥Ü¥Ã¥È³èÍѤȥǡ¼¥¿½¸ÀѤθ½¾õ¡×¤¬3·î24Æü¤Ë³«¤«¤ì¤¿¡£»º¶Èµ»½ÑÁí¹ç¸¦µæ½ê¼óÀʸ¦µæ°÷¤Î²ÆÌÜŰ»á¤Ï¡¢ÈÆÍѥҥȷ¿ ... |
°åÎŵ¡´ï¡¦Âγ°¿ÇÃÇÌôÉô²ñ¡¢ÊÛ¼þ°ÏµÕή¤ò·ÐÈé½èÃ֤ǻߤá¤ë°åÎŵ¡´ï¤ò¾µÇ§Î»¾µ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-30 7:00) |
¡¡¸üÀ¸Ï«Æ¯¾Ê¤Ï2023ǯ3·î27Æü¡¢°åÎŵ¡´ï¡¦Âγ°¿ÇÃÇÌôÉô²ñ¤ò³«¤¡¢ÆüËܥ饤¥Õ¥é¥¤¥ó¤ÎÊÛ¼þ°ÏµÕήÊĺ¿¥»¥Ã¥È¤Î¿·µ¬¾µÇ§¤òλ¾µ¤·¤¿¡£ |
ÊÆGilead¼Ò¡¢IRAK4¤ÎɸŪÃÁÇò¼Áʬ²òͶƳÌô¤òÊÆNurix¼Ò¤«¤éƳÆþ¥ª¥×¥·¥ç¥ó¹Ô»È from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-30 7:00) |
¡¡ÊÆGilead Sciences¼Ò¤Ï2023ǯ3·î20Æü¡¢ÊÆNurix Therapeutics¼Ò¤È2019ǯ¤Ë·ë¤ó¤À·ÀÌó¤Ë´ð¤Å¤¯¥ª¥×¥·¥ç¥ó¸¢¤ò¹Ô»È¤·¡¢IRAK4¡ÊInterleukin 1 Receptor Associated Kinase 4¡Ë¤òɸŪ¤È¤¹¤ë2²Á¤ÎÃÁÇò¼Áʬ²òͶƳÌô¸õ ... |
OIST¡¢ÅìÂç¤È¶¦Æ±³«È¯¤·¤¿¥µ¥ó¥´¤Î´Ä¶DNAʬÀϤÇÍÍÑÀ¤ò³Îǧ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2023-3-30 7:00) |
¡¡²Æì²Ê³Øµ»½ÑÂç³Ø±¡Âç³Ø¡ÊOIST¡Ë¤Ï2023ǯ3·î28Æü¡¢ÅìµþÂç³Ø¤È¶¦Æ±³«È¯¤·¤Æ¤¤¿¥µ¥ó¥´¤Î´Ä¶DNAʬÀÏË¡¤Ë¤Ä¤¤¤Æ¡¢ÍÍÑÀ¤ò³Îǧ¤·¤¿¤Èȯɽ¤·¤¿¡£²ÆìËÜÅç¤ËÀ¸Â©¤¹¤ë¥µ¥ó¥´¤Ë¤Ä¤¤¤Æ¡¢9³ä¤Û¤É¤Î³ÎΨ¤Ç¡¢ÌÜ»ë´Ñ»¡¤È ... |